Please assess the completion status of the following clinical trial:

Trial Title: Combination Medications vs. Patch Alone for Medically-Ill Smokers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* currently smoking at least 10 cigarettes per day (confirmed by high exhaled carbon-monoxide (CO))~* 18 years or older~* interested in quitting within the next 30 days~* one or more pre-defined medical illnesses (including cardiovascular disease, other vascular disease, chronic pulmonary disease, cancer, hypertension, diabetes, hyperlipidemia, and recurrent pulmonary infections)~Exclusion Criteria:~* contraindications to pharmacotherapy (including unstable angina, myocardial infarction within 2 months, severe arrhythmia, seizure disorder, serious mental illness requiring antipsychotic medications)~* current use of other tobacco products (smokeless tobacco, cigars, pipes, etc.), bupropion, clonidine, nortriptyline, or nicotine replacement medications~* unable to give consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Nicotine patch, nicotine inhaler, bupropion
- 2 (Type: ACTIVE_COMPARATOR): Nicotine patch

Based on this trial design, predict the completion outcome and termination type (if applicable).